Strategic Submission Planning
Before moving into an EU submission, it helps to step back and set the strategy first. Pathway decisions, Member State selection, and timing choices made early can have a big impact later.
We work through the plan together so you know exactly where you’re going, what order things should happen in, and how to approach CTIS with fewer surprises.
When teams use this
• Preparing for a first EU CTR or CTA submission
• Deciding on the right pathway or regulatory approach
• Selecting an RMS and Member States
• Aligning timelines across clinical, CMC, and operations
•Wanting a clear plan before building the dossier
What the process looks like
Introductory call
We talk through your program, goals, and overall development strategy.
Program review
I review your clinical plans, CMC readiness, and timelines through an EU regulatory lens.
Pathway and RMS strategy
We outline the most appropriate pathway and discuss RMS and Member State considerations based on predictability, timelines, and risk.
Submission plan
You receive a clear, practical plan that lays out sequencing, dependencies, and next steps.
Follow up support
Brief email support to help you apply the plan and work through questions as they come up.
Why this matters
EU submissions tend to run more smoothly when the strategy is clear from the start. Choosing the right pathway and sequencing activities realistically can prevent delays, rework, and unnecessary complexity later.
A thoughtful plan upfront saves time and reduces risk during execution.
Why ApexVera
You work directly with me. No handoffs. No layers.
I’ve led EU CTR submissions and CTIS workflows and worked through real authority questions. The guidance is practical and based on what actually happens, not theory.
Next steps
If you'd like to talk through your program and see whether a readiness review makes sense, we can start with a short call.